Shenzhen Xiupu Biological Technology Co., Ltd. announced that it expects to receive CNY 100 million in funding from Shenzhen Bioeasy Biotechnology Co., Ltd.
June 27, 2021
Share
Shenzhen Xiupu Biological Technology Co., Ltd. announced a private placement of common shares for the gross proceeds of CNY 100 million on June 28, 2021. The transaction will include participation from existing investor Shenzhen Bioeasy Biotechnology Co., Ltd. Post completion of transaction, the registered capital of the company will increase from CMY 10 million to CNY 110 million and investor will retain 100% stakes in the company. The transaction has been approved at the third meeting of the second board of directors and the third meeting of the second board of supervisors and does not need to be submitted to the company's shareholders meeting.
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing reagents, rapid testing instruments, related testing services and in vitro diagnostic point-of-car testing (POCT) products, such as colloidal gold immunochromatographic test papers, enzyme-linked immunoassay (ELISA) kits, nucleic acids extraction kit, portable food rapid analysis system, infectious disease detection series and fluorescence immunoassay analyzer, etc. Its products are mainly used in dairy, meat, aquatic products, grains and oils, fruits and vegetables and other food fields that require rapid testing, as well as in the cultivation and breeding fields.
Shenzhen Xiupu Biological Technology Co., Ltd. announced that it expects to receive CNY 100 million in funding from Shenzhen Bioeasy Biotechnology Co., Ltd.
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 
